医学
以兹提米比
辛伐他汀
临床终点
急性冠脉综合征
危险系数
安慰剂
内科学
他汀类
心脏病学
心肌梗塞
置信区间
随机对照试验
病理
替代医学
作者
Alon Eisen,Christopher P. Cannon,Michael A. Blazing,Erin A. Bohula,Jeong‐Gun Park,Sabina A. Murphy,Jennifer A. White,Robert P. Giugliano,Eugene Braunwald,on behalf of the IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators
标识
DOI：10.1093/eurheartj/ehw377
摘要
The clinical benefit of adding ezetimibe to statin appears to be enhanced in patients with prior CABG, supporting the use of intensive lipid lowering therapy in these high-risk patients following ACS.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
轨迹
Mufreh
Criminology34
寻道图强
AN
BowieHuang
sys549
无极微光
NattyPoe
toutou
微微旺旺
puterlee
Terry
开放青旋
葡萄柚子
苏木
traveller
yx_cheng
科妍通AI2_1
小蘑菇
iNk
拉哈80
66
皖公网安备34019202002308
